Search
New statistical approach to COVID-19 clinical trials aims to accelerate drug approval process and attract more funding
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
Cybersecurity in the era of COVID-19
By
Cybersecurity remains a priority in the pandemic. Here’s how experts from top firms are tackling COVID-19 scams, phishing, and more.
Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
Using data science to forecast clinical trial outcomes
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
Finance at MIT Ecosystem
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
MIT LFE and Informa Pharma Intelligence launch Project ALPHA
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
MIT Sloan Climate Researcher Wins Education Grant
Professor Christopher Knittel and the MIT Energy Initiative's Aisling O’Grady were one of 14 teams to win a grant from the Jameel World Education Lab.
MIT Faculty Kick off Inauguration Day With Symposium
Ahead of the presidential inauguration, MIT Sloan's Professor Andrew Lo and other panelists described advances in their research and how these discoveries are being deployed to benefit the public.
Solving Food and Agriculture Challenges
By
Professors Retsef Levi and Karen Zheng discussed their work in addressing food and agriculture issues across the globe at MIT Sloan Reunion 2023.